Health Care & Life Sciences

Featured Publication:

A Look At Drawbacks Of Insurers' Prior Authorization Process [Law360]

Jacqueline Green authored an article examining the drawbacks of the prior authorization process used by insurance companies.

More

Cozen O’Connor’s cross-disciplinary health care and life sciences team provides comprehensive services in one of the largest, most dynamic, and fastest-growing sectors of the U.S. economy. The health care and life sciences fields are heavily regulated, and all legal work in this area must be grounded in a specific and sophisticated understanding of applicable laws. We represent and advise companies of all stages that are bringing innovation to the market to achieve better efficiency, accuracy, and outcomes in all aspects of clinical health care. Many of our attorneys hold advanced scientific degrees and have worked at health care and life sciences companies, and we combine this deep industry knowledge with a demonstrated strength across the transactional, regulatory, and litigation areas of the law.

We represent:

  • Investors focused on funding in the health care and life sciences industries, including private equity and venture capital firms.
  • Businesses in all phases of their company lifecycle, from rapidly growing start-ups to mature public companies.
  • Members of the health care sector, including pharmaceutical companies, hospitals and health systems, physician group practices and surgical specialties, long-term care facilities, behavioral health providers, accountable care organizations (ACOs), medical equipment manufacturers and suppliers, academic institutions, tissue banks, and insurers.
  • Members of the life sciences sector, including drug developers, biotechnology companies, medical device manufacturers, and health care entrepreneurs.

The expansive range of skills, knowledge, and experience within the team includes: 

Digital Health

New technologies are transforming the practice of health care. From the growth in telehealth and telemedicine to the revolution in electronic data collection and analysis, digital health is affecting nearly every aspect of health care delivery.

Cozen O’Connor is a leader in digital health law. We represent innovative telehealth and telemedicine companies, technology companies, health care analytics firms, provider groups, and medical device manufacturers. Our attorneys counsel clients on all aspects of digital health, from compliance with analogue-era regulatory requirements to health fraud and abuse laws.

Our attorneys also provide integrated corporate counsel, assisting technology firms and health care companies on corporate structure, private equity, IP, commercialization, licensing, marketing, and contracts. We partner with emerging companies through every stage of their business life cycle. Our attorneys advise digital and tech-focused companies on medical liability risk management and coverage and reimbursement strategies with both government and private payors.

Cozen O’Connor advocates not only for individual digital health clients, but also for the industry as a whole. Through our Washington, D.C.-based Public Strategies firm and State Attorneys General Practice, we provide top-ranked government relations support, track relevant legislative activity, advocate before state and federal governments, and build effective trade associations and policy-based coalitions.

Health Care M&A

Modern health care institutions and non-institutional businesses require legal counsel who are well-versed in both corporate law and health law in order to complete major transactions. Cozen O’Connor brings sophisticated understanding of business, finance, health industry operations, and health regulations to every deal.

Cozen O’Connor serves as transaction counsel for hospitals, health systems, physician groups, ACOs, clinically integrated networks, medical device manufacturers, private equity sponsors and portfolio companies, academic medical centers, and research organizations. We can assist with all facets of a transaction, from initial acquisition structuring, due diligence, antitrust, fraud and abuse, reimbursement, quality of revenue, and tax matters, through document negotiation and implementation and closing. We have extensive experience negotiating joint ventures, alliances, and co-management arrangements, and arrange financing through public and private offerings, bonds, loans, and other investment vehicles. Our team can resolve compliance, antitrust, tax, and bankruptcy issues for health care and life science organizations.

Health Care Private Equity

Cozen O’Connor’s deep understanding of the unique legal, political, regulatory, macroeconomic, and business aspects of the health care industry benefits private equity firms and their portfolio companies when working to meet their strategic goals. Our clients rely on our comprehensive approach to due diligence of targets in the health care space and benefit from the guidance of our health care regulatory counsel. In this capacity, we are counsel to private equity sponsors and portfolio companies and advise in both buy-side and sell-side transactions. Our health care transactions team is current on market trends and market-based contract provisions. We routinely write, speak, and hold seminars on recent developments in the health care private equity space.

Emerging Business Venture Capital

Our team advises life science start-ups at all stages of a company’s lifecycle, from formation through financing and exit planning. Cozen O’Connor’s cross-disciplinary team is knowledgeable in all issues affecting emerging businesses, including employment, intellectual property, tax, real estate, and corporate governance. Our deep involvement in the field and breadth of experience allows the firm to function as a one-stop shop for life science start-ups seeking assistance in developing, protecting, and commercializing their developments and discoveries.

Life Sciences Transactions

Our life sciences transactions team handles all transactional needs in this fast-moving industry. We routinely serve as counsel to biotechnology companies at all stages of their life cycle, including early-stage therapeutics. In this capacity we handle MSAs, CRO agreements, development rights, licensing agreements, royalty contracts, university agreements, lab site development, and we resolve disputes with contract manufacturers. Our experience also includes the arrangement of mergers, acquisitions, consolidations, divestitures, workouts and restructurings; negotiation of joint ventures, alliances, and co-management arrangements; resolution of antitrust, tax, and bankruptcy issues; arrangement of financings through public offerings, bonds, loans, and other investment vehicles.   

Fraud, Abuse, and Compliance

Clinical and non-clinical health care delivery is driven by compliance guidelines under federal and state law. We routinely advise our clients on federal and state fraud and abuse and related compliance matters, such as laws and regulations under the Federal Anti-Kickback Statute, the Federal Physician Self-Referral Prohibition (the Stark Law), the Federal Civil Monetary Prohibitions (CMPs), the Federal False Claims Act (FCA), and other issues arising from Medicare and Medicaid law. We also advise on guidance issued by the Center for Medicare and Medicaid Services (CMS) under the U.S. Department of Health and Human Services (HHS), Office of Inspector General (OIG), or U.S. Department of Justice (DOJ) initiatives, such as Civil Investigation Demands (CIDs) or DOJ referrals for litigation (i.e. criminal enforcement matters). Compliance and enforcement matters routinely arise in the course of health care operations and may be highlighted during transactional activity. Our team is sophisticated in this arena and has a granular understanding of these laws and their implications. Our team offers practical and efficient advice in all matters related to fraud and abuse and compliance.

Provider Payment Disputes and Contracting

Given the current regulatory climate, the need for clear and enforceable payer contracts has never been greater. Cozen O’Connor counsels major health care clients in the areas of payer contracts, clinical integration, and value-based payment programs. Our attorneys are well-versed in the intricacies of payer contracts and their practical implications. We are also nationally known as a “go-to firm” for reimbursement disputes. Clients draw on our deep knowledge of laws governing the Medicare and Medicaid programs, as well as the financial and operational considerations specific to public and private-payor disputes.

Our team offers start-to-finish contract counsel and is well-versed in all types of payer contract issues, including utilization management, “tiering and steering,” and the impact of corporate structure on government payment eligibility. We provide sophisticated front-end payer contract counsel, and we also defend and enforce payer contracts in high-stakes payment disputes, for which we are nationally known and respected. Cozen O’Connor is a recognized leader in value-based contracting and related risk-based payment programs. We also structure accountable care organizations and clinically integrated networks.

The firm represents health systems, hospitals, and drug and device companies in disputes against private insurers, including Medicare Advantage organizations, and federal and state government health care programs. The scope of our experience is vast and includes work on some of the most technically and legally complex disputes of the past decade. We advise on issues involving: Medicare certification, premium subsidies, disputes over Emergency Department (ED) reimbursement, 340B drug payment disputes, diagnosis-related groups (DRGs), enforcement of prompt pay penalties, site-of-service, out-of-network reimbursement, network termination, suspension of payments, continuity-of-care, recoupments, coding downgrades, coverage, ERISA, sequestration, and intergovernmental transfers. We have served as counsel in cases before the Provider Reimbursement Review Board (PRRB), the Departmental Appeals Board (DAB) of the Department of Health and Human Services, and state Medicaid Bureaus of Hearings and Appeals. We regularly appear in state and federal courts on behalf of our clients. In addition, we have achieved successful results for our clients in numerous confidential mediations and arbitrations.

Cozen O’Connor’s practice is unusual in that we are capable of managing large multi-state or multi-plaintiff reimbursement litigation, but are also flexible enough to adjust our service model to meet specific client needs, including through use of alternative or contingency fee agreements.

Hospitals and Health Systems

We represent non-profit and for-profit hospitals and health systems throughout the country on a daily basis in all aspects of their operations, including payor contracting and disputes, Medicare, Medicaid, HIPAA and data privacy and security, compliance, investigations, physician contracting, intellectual property protection and monetization, licensure, vendor contracting, medical staff issues, and governance matters. Several of our lawyers have spent a significant portion of their careers working as lawyers in hospital legal departments and the entire team is cognizant of the unique internal and external dynamics faced by hospital organizations and the executives that run them. We are also routinely involved in hospital mergers and acquisitions, bringing our deep knowledge of the hospital market and applicable laws and regulations as well as our transactional experience to bear to optimize transaction value, protect our client, and complete the transaction as quickly and efficiently as possible.     

Physician Group Practices and Surgical Specialties

The dynamics of physician practice are evolving rapidly with the proliferation of digital health, the increased deployment of non-physician clinical professionals, the rise in asynchronous prescribing, and an increased investment in ancillary services, such as imaging and clinical laboratories. With this evolution, the legal complexity of physician practice has increased exponentially. Cozen O’Connor provides invaluable representation to primary care, surgical, and other specialty physician practices regarding both daily operations and fundamental transactions. We utilize our deep knowledge of, and experience with, issues affecting physician practices such as professional licensing, the use of management services organizations, and risk-based contracting throughout the country. We regularly represent parties on both sides of physician practice acquisitions involving private equity, hospitals and health systems, and other sources of capital.  

Long-Term Care Facilities

Cozen O’Connor’s Health Care and Life Sciences team represents lifetime communities, skilled nursing facilities, and assisted living facilities in billing and tax-exemption compliance, licensure, and general operational and business matters. Our team also has a robust merger and acquisition practice involving lifetime communities and other long-term care facilities. Our breadth of experience with issues that are common to all health care providers, as well as the unique issues faced by long-term care providers who care for some of most vulnerable people in their communities for long periods of time, makes our team well-suited to assist in both day-to-day operations as well as fundamental purchase and sale transactions.

Government Enforcement and Litigation

Cozen O’Connor defends health care clients in high-stakes federal and state agency investigations and litigation, including actions involving False Claims Act, qui tam, Anti-Kickback, Stark Law, and Sunshine Act claims. We are known for our ability to achieve early and decisive resolutions.

Our team has the ability to work in cooperation with Cozen O’Connor Public Strategies, the firm’s bipartisan Washington, D.C.-based government relations firm, which provides outreach to public officials on matters of health law and policy. We advocate for clients before the Centers for Medicaid & Medicare Services, Department of Justice, Food & Drug Administration, state departments of health & welfare, and state and federal legislatures.

The firm’s State Attorneys General Practice, one of the largest in the country, represents clients in state AG investigations and litigation (including multi-state and federal co-enforcement actions). The State AG team has experience counselling health care clients faced with state-based consumer protection, antitrust, false claims, drug pricing, and data privacy claims.

Health Care Privacy & Security

Health data privacy and security is an important issue for all entities operating in the health care sector. Cozen O’Connor’s health care team helps clients meet the challenges of keeping health data secure and ensuring regulatory compliance. We closely track and advise clients on any changes or updates to relevant health privacy and security laws, including HIPAA and HITECH, FTC, FDA, Gramm-Leach Bliley, the GDPR, U.S. Privacy Shield, alcohol and drug abuse records, federal communications and trade statutes, and myriad state-based privacy and data breach laws. We also advise clients handling health care data outside the HIPAA regulatory structure, such as wellness programs, wearable devices, and websites. We assist many new and start-up clients in emerging technology businesses as to any potential HIPAA or privacy obligations they may have.

Among the most important services Cozen O’Connor provides is comprehensive loss prevention. Our attorneys conduct deep-dive audits under the umbrella of attorney-client privilege; develop policies and procedures that integrate sophisticated physical, technical, and administrative safeguards; conduct client training on data privacy and security compliance; and draft and review contracts with covered entities, business associates, subcontractors, and institutional partners.

In response to an alleged privacy violation or data breach, our health care team can perform immediate forensic and recovery operations, satisfy notification obligations, liaise with government officials, and help craft public messages to protect clients from liability. We lead complex internal investigations for high-profile health clients and represent them in federal and state government regulatory investigations, enforcement actions, state attorneys general litigation, class actions, and individual plaintiff lawsuits.

The firm’s work in health data privacy and security is significantly bolstered by our strong, Washington, D.C.-based government affairs and State Attorneys General groups. Cozen O’Connor Public Strategies is at the forefront of tracking legislative developments on health data, and the firm’s State AG Practice is well-positioned to assist with any inquiries at the state level. In addition, COSECURE, an ancillary business of the firm, works under privilege with our health care attorneys to perform HIPAA security risk analyses and forensic investigations upon discovery of security incidents or breaches.

Share on LinkedIn

Experience

Publications

CMS Issues Final Rule Impacting Prior Authorization Process [Health Law Informer Blog]

January 24, 2024

Last week CMS issued its final rule "CMS Interoperability and Prior Authorization" (CMS-0057-F), unchanged from its proposed rule in 2022, which addresses prior authorizations. Prior authorization, a "utilization management" technique, requires a health insurer to consent to a doctor’s proposed...

New York May Be Paving the Way for State-level Cybersecurity Regulations on Health Care Facilities [Health Law Informer Blog]

November 28, 2023

Last month, a cyberattack forced two New York hospitals to divert and even discharge some patients to other facilities, while the affected hospitals shut down their IT systems to address the issue and restore their secure network. [cite] In the wake of this event, New York Governor Kathy Hochul has...

Provider Charged with Receiving and Paying Millions in Kickbacks in Connection with Sober Homes [Health Law Informer Blog]

September 22, 2023

On Friday, September 15th, the United States Attorney’s Office for the District of Massachusetts (United States) and the Massachusetts Attorney General’s Office (Massachusetts) filed a joint complaint in the United States District Court for the District of Massachusetts against a...

Supreme Court Confirms: Subjective Beliefs of Falsity are Fair Game in FCA Lawsuits [Alert]

August 04, 2023

The U.S. Supreme Court held in two consolidated landmark cases that a defendant’s subjective beliefs must be considered in determining whether they knowingly violated the False Claims Act. The ruling will have far-reaching and immediate ramifications in FCA litigation.

Big Data, Big Recovery: The Emergence of Data Analytics in Health Care FCA Enforcement [Alert]

August 04, 2023

Data analytics has notably amplified the investigation of health care claims, but these new approaches have raised concerns within the legal system.

UnitedHealthcare’s Changing Approach to Prior Authorizations [Health Law Informer Blog]

July 13, 2023

Prior authorizations, one of health insurers’ many “utilization management” techniques, is a hot topic amongst practicing physicians, patients, and regulators, to name a few. The prior-authorization process requires a health insurer to consent to a doctor's proposed course of treatment for a...

HHS Proposes $9 Billion Lump Sum Payment for Hospitals to Remedy Unlawful 340B Payment Reductions [Health Law Informer Blog]

July 10, 2023

On Friday, July 7, 2023, the Centers for Medicare & Medicaid Services (CMS) published their long-awaited proposed remedy to the unlawful 340B drug payment reductions. Background: In 2018, CMS significantly reduced the Average Sales Price (ASP) plus six-percent (6%) formula for calculating...

A Look At Drawbacks Of Insurers' Prior Authorization Process [Law360]

April 13, 2023

Jacqueline Green authored an article examining the drawbacks of the prior authorization process used by insurance companies.

Will The Standard of Liability Under The 60-Day Repayment Rule Change? [Health Law Informer Blog]

February 21, 2023

At the end of last year, the Centers for Medicare & Medicaid Services (CMS) proposed changes to the so-called 60-day repayment rule. The proposed changes include eliminating the current “reasonable diligence” standard that applies to providers in connection with potential liability for...

New Jersey Health Care Entities Should Add New Employee Protections to Their Due Diligence Checklists [Alert]

October 28, 2022

New Jersey Senate Bill No. 315 creates broad protections for many employees in the health care sector in the event of a change in control.

New Protections for Employees of Certain New Jersey Health Care Entities [Health Law Informer Blog]

October 27, 2022

Health care entities, home health care agencies, and staffing registries considering a transaction in New Jersey will need to keep in mind new obligations to certain employees. On August 18, 2022, Governor Murphy signed into law New Jersey Senate Bill No. 315 (the “Act”), which created broad...

En Banc Fourth Circuit Affirms Dismissal of False Claims Act Lawsuit and Vacates Panel Opinion [Health Law Informer Blog]

October 14, 2022

We previously reported that the Fourth Circuit, via a 2-1 decision in United States ex rel. Sheldon v. Allergan Sales, LLC, 24 F.4th 340 (4th Cir. 2022), affirmed the dismissal of a False Claims Act (“FCA”) qui tam lawsuit against Forest Laboratories, LLC (“Forest”). The plaintiff alleged that...

Industry Interactions with Physicians Continue to be a Hot Topic for Civil False Claims Act Enforcement Actions under Private Qui Tam Litigation [Health Law Informer Blog]

October 06, 2022

In a continuing wave of fraud and abuse civil enforcement actions brought by qui tam relators, big pharma giant, Biogen, is the latest corporate actor to reach a mega settlement with the U.S. Department of Justice (DOJ) for allegations of False Claims Act liability for paying bribes to physicians...

HIPAA “Right of Access” Enforcement Trend Continues [Health Law Informer Blog]

September 27, 2022

The Office of Civil Rights of the Department of Health and Human Services (“OCR”) announced the resolution of three more right of access cases, bringing the total to a whopping 41 since the start of its drive to increase compliance with this Health Insurance Portability and Accountability Act...

Sham Transactions in Digital Health Industry [Health Law Informer Blog]

September 23, 2022

In its recently published Special Fraud Alert, the Office of Inspector General (“OIG”) presented a list of suspect characteristics related to arrangements with telehealth and telemedicine companies, which may help determine the potential for fraud. The OIG developed this list based on dozens of...

New Final Rules under the No Surprises Act: Four Takeaways [Health Law Informer Blog]

September 14, 2022

On August 19, 2022, the United States Departments of Health and Human Services, Labor and Treasury released final rules (“Final Rules”) revising certain provisions of their previously issued interim final rules regarding the No Surprises Act (“NSA”). The revisions reflect some comments received...

Office of Civil Rights Releases Patient Privacy Guidance in the Wake of Dobbs Decision [Health Law Informer Blog]

July 01, 2022

Patient privacy concerns are at an all-time high following the Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization. Following their statements affirming that abortion constitutes basic and essential health to which every woman should be entitled issued by both Xavier Becerra,...

CMS Releases Second Set of FAQs Regarding Good Faith Estimates to Uninsured and Self-pay Patients Under “No Surprises Act” [Health Law Informer Blog]

April 06, 2022

CMS continued to roll out guidance regarding the No Surprises Act. The latest guidance is the second set of FAQs regarding the Good Faith Estimate Requirement for uninsured and self-pay patients was issued on April 5, 2022. The FAQs address six questions regarding the requirement and can be found...

Federal District Court Partially Guts Regulations Affecting the No Surprises Act Arbitration Process [Health Law Informer Blog]

March 30, 2022

On February 23, 2022, the U.S. District Court for the Eastern District of Texas gutted portions of the interim final rule affecting the independent dispute resolution (“IDR”) process of the No Surprises Act (the “Act”). Tex. Med. Ass’n v. U.S. Dep’t of Health & Human Servs., No....

Fourth Circuit Adopts Safeco Scienter Standard to Prove False Claims Act Violation in Legal Falsity Cases [Health Law Informer Blog]

March 09, 2022

A few weeks ago, the U.S. Court of Appeals for the Fourth Circuit answered a critical inquiry in the False Claims Act (“FCA”) context: does a defendant violate the FCA when its reading of the regulation is objectively reasonable and there is no government guidance discouraging or rejecting that...

Compliance with the hospital price transparency law almost a year in: Where are we now? [Cosmos]

December 01, 2021

Christopher Raphaely and Danielle Sapega co-authored an article about the Centers for Medicare & Medicaid Services (CMS) hospital price transparency rule, which has been in effect since January 1, 2021.

Five Things Providers Need To Know About The New Interim Final Rule Under The “No Surprises” Act [Health Law Informer Blog]

October 05, 2021

On Thursday, September 30, 2021, The United States departments of Health and Human Services (“HHS”), Labor and Treasury released an interim final rule (“Rule”) that completes most of the regulatory framework under the federal No Surprises Act (“Act”). The Act largely bars balance billing of...

US and Tyler Texas Chambers of Commerce Sue Feds to Block Portions of the Health Plan Transparency Rule [Health Law Informer Blog]

August 12, 2021

Two chambers of commerce, the Chamber of Commerce the United States of America and the Tyler (TX) Area Chamber of Commerce, filed a lawsuit on August 10, 2021, in the US District Court for the Eastern District of Texas against the United States departments of Health and Human Services, Labor and...

Prescription Privileges for Psychologists: The State of Play [American Bar Association]

July 28, 2021

Gregory Fliszar and Ryan Portugal co-authored an article examining the arguments for and against psychologists obtaining prescription privileges for psychotropic drugs and a look at the five states that have granted such privileges to psychologists.

AstraZeneca Sues HHS over Drug Pricing Program Advisory Opinion Regarding Contract Pharmacies

February 01, 2021

Corrine Zucker discusses AstraZeneca's complaint filed in Delaware federal court against HHS for issuing an invalid Advisory Opinion

Repeal of McCarran-Ferguson Act — Ramifications for Insurance Clients

January 25, 2021

Jonathan Grossman discusses how the Competitive Health Insurance Reform Act will impact health insurance companies, as they are now no longer immune from antitrust scrutiny for activities previously found to be “the business of insurance.”

Trump vs. Biden: HEALTH CARE POLICY

October 28, 2020

Alex Campau, Mark Alderman, and Brett Banker discuss the similarities and differences between Trump and Biden's health care policies.

Pennsylvania Attorney General Announces Nursing Home Criminal Investigations [Alert]

May 15, 2020

Danielle Sapega discusses the Pennsylvania attorney general's investigation into nursing homes, the Department of Health's guidance for nursing homes, and the governor's executive order granting immunity to health care workers.

Pennsylvania Hospitals Can Now Resume Elective Surgeries and Procedures [Alert]

April 29, 2020

Gregory M. Fliszar discusses what measures Pennsylvania hospitals must take before resuming elective surgeries and procedures.

CMS Issues Blanket Waivers for Long-Term Care Facilities, SNFs and NFs

April 29, 2020

J. Nicole Martin and Gregory M. Fliszar discuss CMS's blanket waivers for nursing facilities and skilled-nursing facilities effective through the end of the COVID-19-related emergency.

CMS Issues Recommendations to Reopen Health Care Systems in Areas with Low Incidence of COVID-19 [Alert]

April 20, 2020

J. Nicole Martin and Gregory M. Fliszar discuss CMS's guidance for health care systems in areas with low COVID-19 infections to reopen nonessential care.

CMS Announces Enhanced Nursing Home Reporting Requirements

April 20, 2020

Danielle E. Sapega and Gregory M. Fliszar discuss CMS's new guidance for nursing homes when it comes to reporting confirmed or suspected cases of COVID-19.

CMS Releases Details on $30 Billion Payment to Hospitals and other Health Care Providers [Alert]

April 14, 2020

Gregory M. Fliszar and Alexandra Campau explain the terms and conditions outlined by CMS for providers who wish to receive a payment from the Public Health and Social Services Emergency Fund.

OCR Releases Notification of Enforcement Discretion at COVID-19 Community-Based Testing Sites [Alert]

April 14, 2020

Danielle Sapega and Gregory M. Fliszar discuss OCR's announcement relaxing HIPAA rules in connection with the good faith participation in the operation of a COVID-19 Community-Based Testing Site(s)

First $30 Billion to be Immediately Distributed to Hospitals, Other Health Care Providers

April 09, 2020

Gregory M. Fliszar discusses CMS's announcement that $30 billion will be distributed from the health care provider relief fund in the CARES Act.

OCR Loosens Restrictions on Business Associates in Response to the COVID-19 Pandemic [Alert]

April 03, 2020

Gregory M. Fliszar explains HHS's announcement that it will exercise its enforcement discretion and will not impose penalties for violations of certain provisions of the HIPAA Privacy Rule against health care providers or their business associates for the good faith uses and disclosures of protected health information.

Summary and Analysis of Key Provisions of the CARES Act

March 28, 2020

Members of Cozen O'Connor's Coronavirus Task Force provide analysis of the CARES Act and how it will impact small businesses, distressed industries, employers and employees, taxes, and the health care, real estates, and energy industries.

OCR Releases Guidance on the Disclosure of PHI to First Responders and Public Health Authorities [Alert]

March 26, 2020

Danielle E. Sapega and Gregory M. Fliszar discuss the latest guidance from OCR on when it is permissible to disclose the minimum necessary information of individuals infected with COVID-19.

The Use of Telehealth During the COVID-19 Nationwide Public Health Emergency [Alert]

March 23, 2020

Greg Fliszar and Chris Raphaely explain the recent changes OCR and HHS made to make telehealth services more available.

HHS Issues EMTALA Waivers As a Result of the COVID-19 Pandemic [Alert]

March 18, 2020

Greg Fliszar discusses HHS's waiver of certain requirements of EMTALA in an effort to help hospitals being overrun and having capacity issues in their emergency rooms as a result of the COVID-19 pandemic.

HIPAA and COVID-19: Balancing Public Health Concerns and Patient Privacy in the Midst of a Pandemic [Alert]

March 13, 2020

Gregory M. Fliszar and Danielle Sapega discuss the HIPAA Privacy and Novel Coronavirus bulletin and what providers and covered entities need to know during a public health emergency.

Events & Seminars

Upcoming Events

PBI Health Law Institute 2024

March 12, 2024 - Harrisburg, PA

Christopher Raphaely will present at the 2024 Pennsylvania Bar Institute’s Health Law Institute.

Celebrating Women in Health and Life Sciences

March 08, 2024 - Toronto, ON

Atoussa Mahmoudpour will be speaking at the OBIO Networking with Inspirational Women in Science event, Celebrating Women in Health and Life Sciences.

Past Events

Access to Innovation 2024

February 28, 2024 - Vancouver, BC

Health Law 2024

December 05, 2023 - Philadelphia, PA

The State of Life Sciences in Philadelphia

June 21, 2023 - Philadelphia

Spring Institute

March 18, 2022 - Philadelphia, PA

PBI Health Law Institute 2022

March 15, 2022 - Webinar

Health Law 2022

December 08, 2021 - Webinar

New Vaccine Mandates from Biden Administration

September 23, 2021 - Webinar

Telehealth in the New Administration

June 11, 2021 - Webinar

Price Transparency

March 16, 2021 - Webinar

Health Law 2021

December 07, 2020 - Webinar

PBI Health Law Institute 2020

March 11, 2020 - Philadelphia, PA

Health Law 2020

December 04, 2019 - Philadelphia, PA

Best Practices for Working with Your Outside Counsel

November 19, 2019 - Philadelphia, PA

PBI Health Law Institute 2019

March 12, 2019 - Philadelphia, PA

In The News

James Billings-Kang Named Fellow of the American Bar Foundation

August 21, 2023

James Billings-Kang, a member of Cozen O'Connor's Health Care & Life Sciences Practice, has been named a fellow of the American Bar Foundation.

Best Lawyers Honors More Than 200 Cozen O'Connor Attorneys to its Best Lawyers in America 2024 Edition

August 17, 2023

Best Lawyers selected 232 Cozen O’Connor lawyers from 24 of the firm’s U.S. offices for inclusion in the 2024 edition of The Best Lawyers in America.

Cozen O’Connor Picks Attorney Atoussa Mahmoudpour to Lead its New Canadian Life Sciences & Technology Practice

July 24, 2023

Atoussa Mahmoudpour has joined its North American Corporate Law group and will chair its new Canadian Life Sciences & Technology practice.

As Tech Market Heats Up, More Firms Are Ready For Denver

June 12, 2023

Curtis Vock was quoted in Law360 discussing the growth of tech and life sciences in Denver and Boulder, Colorado.

Eighty-eight Cozen O’Connor Lawyers, 23 Practices Earn Top Recognition in Chambers USA 2023 Guide

June 05, 2023

Of the 88 lawyers ranked, 17 lawyers have been recognized nationally, and eighteen were recognized in Band 1. Eight of the firm's practice areas have been recognized nationally, and nine were ranked Band 1.

Where telemedicine is headed now that the PHE has ended

May 30, 2023

Christopher Raphaely engaged in a Q&A with Healthcare IT News on the anticipated developments involving health care and health care IT following the conclusion of the COVID-19 public health emergency.

The Long and Winding Road – The Saga of the Unlawful 340B Drug Underpayments

May 24, 2023

Greg Fliszar joined the Hospital Finance Podcast to discuss the ongoing legal battle between the U.S. government and the hospital industry.

Cozen O’Connor Recognized as a “Best Law Firm” in 30 Practice Areas Nationwide, 115 Practice Areas Regionally

November 30, 2022

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 30 practice areas nationwide and 115 practice areas regionally.

More Than 200 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch

August 22, 2022

210 Cozen O’Connor lawyers from 24 of the firm’s nationwide offices for inclusion in the 2023 edition of The Best Lawyers in America.

13 Cozen O'Connor Attorneys Named 2022 D.C. Super Lawyers and Rising Stars

July 12, 2022

Super Lawyers has named 13 Cozen O’Connor attorneys to its 2022 Washington D.C. Super Lawyers and Rising Stars lists.

Cozen O'Connor Attorneys Appointed by the American Bar Association

July 01, 2022

The American Bar Association (ABA) has appointed Gregory Fliszar and Aselle Kurmanova to leadership positions in their Health Law and Business Law sections.

Chambers Ranks 86 Cozen O’Connor Lawyers, 22 Practice Areas in Chambers USA 2022 Guide

June 02, 2022

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 86 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2022 edition.

49 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

June 01, 2022

Super Lawyers has selected 49 Cozen O'Connor attorneys to the 2022 Pennsylvania Super Lawyers and Rising Stars lists.

Cozen O’Connor Continues Expansion of Health Care Practice Hiring Litigator James Billings-Kang

November 08, 2021

James will advise the firm’s health care clients in connection with litigation matters arising from provider-payor disputes, False Claims Act matters, private equity transactions, and merger activity, in addition to other complex commercial litigation issues.

Cozen O’Connor Recognized as a “Best Law Firm” in 29 Practice Areas Nationwide, 121 Practice Areas Regionally

November 04, 2021

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 29 practice areas nationwide and 121 practice areas regionally.

Cozen O’Connor Adds Distinguished Patent Counselor and Life Sciences Strategist Todd B. Buck, Ph.D. to the Washington, D.C. Intellectual Property and Business Law Practices

September 22, 2021

Buck brings an impressive resume with over two decades of experience in the life sciences intellectual property sector.

More Than 205 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 19, 2021

Best Lawyers selected 210 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2022 edition of The Best Lawyers in America.

47 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

May 28, 2021

Super Lawyers has selected 47 Cozen O'Connor attorneys to the 2021 Pennsylvania Super Lawyers and Rising Stars lists.

82 Cozen O’Connor Lawyers, 19 Practices Earn Top Recognition in Chambers USA 2021 Guide

May 26, 2021

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 82 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2021 edition; of those, 15 lawyers have been recognized nationally.

Cozen O’Connor Continues Expansion of Health Care Practice with Aselle Kurmanova

May 18, 2021

Kurmanova joins the firm from Seyfarth Shaw LLP, reuniting with John Shire, who joined the firm in November 2020.

4 healthcare antitrust issues to watch

March 01, 2021

Jonathan Grossman was featured in an article published by Healthcare Dive discussing four health care antitrust issues to watch.

Cozen O’Connor Recognized as a “Best Law Firm” in 25 Practice Areas Nationwide, 115 Practice Areas Regionally

November 05, 2020

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 25 practice areas nationwide and 115 practice areas regionally.

Cozen O’Connor Makes Strategic Move Adding John D. Shire to Washington, D.C. Health Care Practice

November 02, 2020

Shire brings a deep understanding of federal and state health care regulations and has been instrumental in several of the most well-known transactions in the health care space.

200 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 20, 2020

Best Lawyers selected 200 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2021 edition of The Best Lawyers in America© (Copyright 2020 by Woodward/White, Inc., of Aiken, SC).

63 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2020 Guide

May 14, 2020

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 63 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2020 edition.

Psychiatrists start support line for doctors fighting coronavirus

May 07, 2020

Greg Fliszar and a group of psychiatrists launched the Physician Support Line to help doctors deal with the stress of combating the coronavirus crisis, with more than 600 people now volunteering in shifts to help.

Pro Bono Lawyers at Weber Gallagher, Cozen O'Connor and Other Firms Have Gotten Creative in COVID-19 Response

May 06, 2020

Greg Fliszar and Danielle Sapega were quoted in The Legal Intelligencer about their pro bono work with the Physician Support Line during the COVID-19 pandemic.

County officials say they must know more about patients to help first responders

April 10, 2020

Greg Fliszar was quoted in The Citizens' Voice discussing what hospitals and health systems can release publicly regarding coronavirus due to HIPAA.

Hospitals Tackling Virus May Need More Than Brief Privacy Waiver

March 19, 2020

Chris Raphaely discussed with Bloomberg Law about HHS using a relax enforcement of the privacy requirements during the public health emergency.

Greg Fliszar Named Co-Chair to ABA Joint Opioid Task Force

September 30, 2019

Greg Fliszar has been named a co-chair of the American Bar Association’s Joint Opioid Task Force (Opioid Task Force).

How In-House Lawyers Can Help Health Care Institutions Fight Costly Data Breaches

September 04, 2019

Greg Fliszar discussed with Law.com how health care providers are handling the rising number of serious data breaches that affect patients.

Trump Administration Expands Pre-Tax Accounts for Health Insurance

June 13, 2019

Alex Campau discussed with The Wall Street Journal about how employees will now be able to use HRAs to buy individual coverage, with certain restrictions, starting January 2020.

57 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2019 Guide

April 25, 2019

Chambers USA, the leading annual guide to the top lawyers and law firms in the USA, has ranked 57 Cozen O’Connor lawyers as leaders in their respective fields in the Guide’s 2019 edition.

Contacts

R. Christopher Raphaely

Co-Chair, Health Care & Life Sciences

craphaely@cozen.com

(215) 665-2099

John D. Shire

Co-Chair, Health Care & Life Sciences

jshire@cozen.com

(202) 747-0775

Gregory M. Fliszar

Vice Chair, Health Care & Life Sciences

gfliszar@cozen.com

(215) 665-4737

People

Awards

Best Lawyers Honors More Than 200 Cozen O'Connor Attorneys to its Best Lawyers in America 2024 Edition

August 17, 2023

Best Lawyers selected 232 Cozen O’Connor lawyers from 24 of the firm’s U.S. offices for inclusion in the 2024 edition of The Best Lawyers in America.

Eighty-eight Cozen O’Connor Lawyers, 23 Practices Earn Top Recognition in Chambers USA 2023 Guide

June 05, 2023

Of the 88 lawyers ranked, 17 lawyers have been recognized nationally, and eighteen were recognized in Band 1. Eight of the firm's practice areas have been recognized nationally, and nine were ranked Band 1.

Cozen O’Connor Recognized as a “Best Law Firm” in 30 Practice Areas Nationwide, 115 Practice Areas Regionally

November 30, 2022

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 30 practice areas nationwide and 115 practice areas regionally.

13 Cozen O'Connor Attorneys Named 2022 D.C. Super Lawyers and Rising Stars

July 12, 2022

Super Lawyers has named 13 Cozen O’Connor attorneys to its 2022 Washington D.C. Super Lawyers and Rising Stars lists.

Chambers Ranks 86 Cozen O’Connor Lawyers, 22 Practice Areas in Chambers USA 2022 Guide

June 02, 2022

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 86 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2022 edition.

49 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

June 01, 2022

Super Lawyers has selected 49 Cozen O'Connor attorneys to the 2022 Pennsylvania Super Lawyers and Rising Stars lists.

Cozen O’Connor Recognized as a “Best Law Firm” in 29 Practice Areas Nationwide, 121 Practice Areas Regionally

November 04, 2021

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 29 practice areas nationwide and 121 practice areas regionally.

More Than 205 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 19, 2021

Best Lawyers selected 210 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2022 edition of The Best Lawyers in America.

47 Cozen O'Connor Attorneys Named Pennsylvania Super Lawyers and Rising Stars

May 28, 2021

Super Lawyers has selected 47 Cozen O'Connor attorneys to the 2021 Pennsylvania Super Lawyers and Rising Stars lists.

82 Cozen O’Connor Lawyers, 19 Practices Earn Top Recognition in Chambers USA 2021 Guide

May 26, 2021

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 82 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2021 edition; of those, 15 lawyers have been recognized nationally.

Cozen O’Connor Recognized as a “Best Law Firm” in 25 Practice Areas Nationwide, 115 Practice Areas Regionally

November 05, 2020

U.S. News & World Report and Best Lawyers recognized Cozen O’Connor as a “Best Law Firm” in 25 practice areas nationwide and 115 practice areas regionally.

200 Cozen O’Connor Attorneys Named Best Lawyers and Ones to Watch By The Best Lawyers In America

August 20, 2020

Best Lawyers selected 200 Cozen O’Connor lawyers from 23 of the firm’s nationwide offices for inclusion in the 2021 edition of The Best Lawyers in America© (Copyright 2020 by Woodward/White, Inc., of Aiken, SC).

63 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2020 Guide

May 14, 2020

Chambers USA, the leading annual guide to the top lawyers and law firms in the United States, has ranked 63 Cozen O’Connor lawyers as leaders in their respective fields in the guide’s 2020 edition.

57 Cozen O’Connor Lawyers, 16 Practices Earn Top Recognition in Chambers USA 2019 Guide

April 25, 2019

Chambers USA, the leading annual guide to the top lawyers and law firms in the USA, has ranked 57 Cozen O’Connor lawyers as leaders in their respective fields in the Guide’s 2019 edition.

125 Cozen O’Connor Attorneys Named to the Best Lawyers in America

August 22, 2018

One hundred twenty-five Cozen O’Connor lawyers from 20 of the firm’s national offices have been selected for inclusion in the 2018 edition of The Best Lawyers in America.

Related Practice Areas

Related Blogs

Health Law Informer

Providing updated news and analysis concerning the world of health law.

Upcoming Event:

Celebrating Women in Health and Life Sciences

Toronto, ON 03/08/2024

Atoussa Mahmoudpour will be speaking at the OBIO Networking with Inspirational Women in Science event, Celebrating Women in Health and Life Sciences.

Event Details

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.